Table 2.
Clinical data of type 2 diabetic patients in respect to the duration of disease classified by using NCEP-ATPIII criteria.
| Males | N | Age (y) | Fasting (mg/dL) | BMI (kg/m2) | SBP (mmHg) | DBP (mmHg) | Pulse | Cholesterol (mg/dL) | Triglyceride (mg/dL) | HDL-C (mg/dL) | Prevalence, % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| All males | 504 | 55 ± 9.15 | 140 ± 63.27 | 24.7 ± 3.23 | 132.7 ± 19.2 | 76.7 ± 10.3 | 87 ± 10.8 | 155 ± 54 | 137 ± 64.2 | 50 ± 18.6 | 41 |
| Duration (0–5 y) | 339 | 53.5 ± 8.9 | 136.8 ± 54.9 | 24.9 ± 3.8 | 132.4 ± 20 | 77.9 ± 11.7 | 88 ± 11.4 | 155.7 ± 55.3 | 132.3 ± 60.4 | 51.4 ± 23.6 | 37 |
| Duration (6–10 y) | 104 | 56.2 ± 9.7 | 149.2 ± 59.9 | 24.8 ± 4.8 | 130.9 ± 20.8 | 74.9 ± 9.8 | 86.6 ± 11 | 155.9 ± 47.6 | 144.6 ± 90.8 | 48.2 ± 23.1 | 39.4 |
| Duration (>10 y) | 61 | 60.25 ± 9.1 | 139.9 ± 54.8 | 23.5 ± 2.5 | 137.3 ± 22.8 | 72.8 ± 10.4 | 86.6 ± 10.1 | 152 ± 65.9 | 135.2 ± 66.1 | 45.7 ± 19.5 | 39 |
| Females | |||||||||||
| All females | 196 | 53.1 ± 9.6 | 157.8 ± 70 | 25.9 ± 4.3 | 127 ± 16.1 | 74.2 ± 9.6 | 92 ± 12.9 | 169.3 ± 49 | 138.8 ± 67.8 | 49.8 ± 22.9 | 58.20 |
| Duration (0–5 y) | 130 | 51.7 ± 8.84 | 154.4 ± 64.6 | 26.1 ± 4.3 | 126.3 ± 15.9 | 74.6 ± 9.7 | 91.8 ± 10 | 170.8 ± 43.8 | 138.1 ± 64.9 | 49.3 ± 24.5 | 53 |
| Duration (6–10 y) | 50 | 54.62 ± 11.08 | 149.7 ± 52.3 | 26 ± 4.28 | 131 ± 19.7 | 73.8 ± 10.8 | 90.5 ± 10.3 | 166.8 ± 50.1 | 132.9 ± 59.5 | 49.4 ± 19.8 | 56 |
| Duration (>10 y) | 16 | 59.31 ± 10.4 | 210 ± 78.2 | 23.1 ± 3.45 | 123.7 ± 17.8 | 71 ± 9.94 | 98.8 ± 21 | 165.1 ± 54.5 | 163.1 ± 65.9 | 55.2 ± 15 | 68 |
Data are presented as mean ± SD.
BMI = body mass index; DBP = diastolic blood pressure; HDL-C = high density lipoprotein cholesterol; SBP = systolic blood pressure.